User profiles for Andrei Seferian
 | Andrei SeferianUniversité Paris-Sud, Hôpital Bicêtre, AP-HP, Inserm UMR-S999, 78 Rue du Général … Verified email at bct.aphp.fr Cited by 2957 |
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
…, C Rotondo, M Rubio-Rivas, A Seferian… - The Lancet …, 2020 - thelancet.com
Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to …
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to …
Pathogenesis of pulmonary arterial hypertension: lessons from cancer
…, N Ricard, C Sattler, A Seferian… - European …, 2013 - Eur Respiratory Soc
Although the causal pathomechanisms contributing to remodelling of the pulmonary vascular
bed in pulmonary arterial hypertension (PAH) are still unclear, several analogous features …
bed in pulmonary arterial hypertension (PAH) are still unclear, several analogous features …
Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension
…, M Riou, P Roblot, O Sanchez, A Seferian… - American journal of …, 2021 - atsjournals.org
Rationale: The relationship between the initial treatment strategy and survival in pulmonary
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …
Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle–like cells in pulmonary …
…, C Phan, R Thuillet, C Sattler, E Fadel, A Seferian… - Circulation, 2014 - Am Heart Assoc
Background— Pericytes and their crosstalk with endothelial cells are critical for the
development of a functional microvasculature and vascular remodeling. It is also known that …
development of a functional microvasculature and vascular remodeling. It is also known that …
Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
…, S Bulifon, X Jaïs, F Parent, A Seferian… - European …, 2020 - Eur Respiratory Soc
Background Viral respiratory infections are the main causes of asthma exacerbation. The
susceptibility of patients with asthma to develop an exacerbation when they present with …
susceptibility of patients with asthma to develop an exacerbation when they present with …
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
…, D Amar, L Savale, P Dorfmüller, A Seferian… - The Lancet …, 2017 - thelancet.com
Background Bi-allelic mutations of the EIF2AK4 gene cause heritable pulmonary veno-occlusive
disease and/or pulmonary capillary haemangiomatosis (PVOD/PCH). We aimed to …
disease and/or pulmonary capillary haemangiomatosis (PVOD/PCH). We aimed to …
Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertension
…, A Berezne, P Dorfmüller, A Seferian… - Arthritis & …, 2012 - Wiley Online Library
Objective Pulmonary venoocclusive disease (PVOD) is an uncommon form of pulmonary
hypertension (PH) characterized by obstruction of small pulmonary veins. Pulmonary venous …
hypertension (PH) characterized by obstruction of small pulmonary veins. Pulmonary venous …
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
…, L Savale, X Jaïs, A Seferian… - European …, 2017 - Eur Respiratory Soc
This study aimed to describe the long-term outcomes of pulmonary arterial hypertension (PAH)
induced by dasatinib. 21 incident, right heart catheterisation-confirmed cases of dasatinib-…
induced by dasatinib. 21 incident, right heart catheterisation-confirmed cases of dasatinib-…
Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease
…, I Zendah, J Le Pavec, A Seferian… - European …, 2015 - Eur Respiratory Soc
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension
characterised by predominant remodelling of pulmonary venules. Bi-allelic mutations in the …
characterised by predominant remodelling of pulmonary venules. Bi-allelic mutations in the …
Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
…, A Beurnier, S Bulifon, A Seferian… - European …, 2021 - Eur Respiratory Soc
A high prevalence of venous thromboembolism (VTE) has been reported during intensive
care unit (ICU) hospitalisation in patients with severe coronavirus disease 2019 (COVID-19) [1…
care unit (ICU) hospitalisation in patients with severe coronavirus disease 2019 (COVID-19) [1…